Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Tachykinin antagonists specifically claimed for asthma by Merck

Feb. 25, 1999

Purinoceptor antagonists claimed by Astra, useful for inflammatory diseases

Feb. 24, 1999

Dura and Spiros update joint development programs

Feb. 24, 1999

Janssen presents selective IL-5 production inhibitors for allergic and inflammatory disorders

Feb. 23, 1999

Serevent now available in Canada as a treatment for chronic obstructive pulmonary disease

Feb. 22, 1999

Structurally novel antiinflammatory/antiallergic agents in the Astra pipeline

Feb. 22, 1999

Potent bradykinin antagonists developed at Fournier

Feb. 19, 1999

FR-167653 compared to dexamethasone in acute lung inflammation

Feb. 18, 1999

PathoGenesis's CF treatment approved in Canada and Argentina

Feb. 17, 1999

S-5920 superior to methylprednisolone in protecting against ARDS

Feb. 17, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...